TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Surgical Science Sweden AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
592,990
|
536,284
|
266,696 |
Financial expenses |
441
|
13,020
|
16,685 |
Earnings before taxes |
180,186
|
139,108
|
47,848 |
EBITDA |
164,402
|
121,746
|
56,513 |
Total assets |
3,158,665
|
3,106,993
|
2,892,625 |
Current assets |
665,758
|
552,209
|
448,574 |
Current liabilities |
157,801
|
204,418
|
168,969 |
Equity capital |
2,918,568
|
2,830,937
|
2,606,820 |
- share capital |
1,713
|
1,697
|
1,847 |
Employees (average) |
249
|
227
|
121 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
92.4%
|
91.1%
|
90.1% |
Turnover per employee |
2,381
|
2,362
|
2,204 |
Profit as a percentage of turnover |
30.4%
|
25.9%
|
17.9% |
Return on assets (ROA) |
5.7%
|
4.9%
|
2.2% |
Current ratio |
421.9%
|
270.1%
|
265.5% |
Return on equity (ROE) |
6.2%
|
4.9%
|
1.8% |
Change turnover |
53,944
|
291,191
|
190,493 |
Change turnover % |
10%
|
119%
|
250% |
Chg. No. of employees |
22
|
106
|
64 |
Chg. No. of employees % |
10%
|
88%
|
112% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.